Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia

This study evaluated the safety and efficacy of anidulafungin, a novel echinocandin, in patients with invasive candidiasis, including candidemia. A total of 123 eligible patients were randomized to one of three intravenous regimens, 50, 75, or 100 mg once daily. Treatment continued for 2 weeks beyon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Krause, David S., Reinhardt, John, Vazquez, Jose A., Reboli, Annette, Goldstein, Beth P., Wible, Michele, Henkel, Timothy
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2004
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC415613/
https://ncbi.nlm.nih.gov/pubmed/15155194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.6.2021-2024.2004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados